
Respiratory transfusion reactions represent some of the most severe adverse reactions to receiving blood products. Transfusion-related acute lung injury (TRALI) is associated with elevated morbidity and mortality. This review assesses emerging concepts such as how EVs: 1. Mediate TRALI; 2. Represent targets for therapeutic to prevent or treat TRALI. 3. Serve as biochemical biomarkers facilitating TRALI diagnosis and detection in at-risk patients.
Like
Save
Share